Apotheek Charlotte De Splenter Ename financials
A multi-period view of the public annual-account figures reported for Apotheek Charlotte De Splenter Ename, with comparable measures and links to available source documents.
Company overviewRegistry number
0880716151
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Apotheek Charlotte De Splenter Ename
2025 versus 2024
- Operating line
- €216,722
- EBITDA
- €78,722
- Total assets
- €371,200
- Equity
- €218,940
+20.8%
-20.7%
+2.2%
+2.6%
EBITDA margin +36.3% · Equity ratio +59%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €216,722 | €78,722 | €371,200 | €218,940 | - |
| 202430 Jun 2024 | €179,475 | €99,252 | €363,197 | €213,301 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.